Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action modulators |
Mechanism BCKDHA modulators(branched chain keto acid dehydrogenase E1 subunit alpha modulators), BCKDHB modulators(branched chain keto acid dehydrogenase E1 subunit beta modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Maple Syrup Urine Disease | Preclinical | United States | 15 May 2025 |





